Skip to main content

Closed

PRME: Prime Medicine, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-5121.8%

ROIC-77.4%

Financially safe

Stretched

Debt / equity1.49×

Interest coverage0.0×

Current ratio3.80×

Prime Medicine, Inc.

PRMENASDAQ Global Market·USD·Closed

Prime Medicine, Inc.

PRMENASDAQ·USD·Closed

$2.92

−3.31%

$2.92

−$0.10 (3.31%)

52W Range

6thpctl

Volume

0.55×avg

Mkt Cap

527.40MUSD

P/E

-2.3TTM

Div Yield

–ann

52W Range

6thpctl

Volume

0.55×avg

Market Cap

527.40MUSD

P/E Ratio

-2.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings